DYRK2 and colorectal cancer: Microarray data from patients with colorectal cancer showed that 65.06% of tumor samples had low DYRK2 mRNA expression, whereas only 34.94% of the adjacent paracancerous tissue samples had low DYRK2 mRNA levels [16].